The Alzheimer's Disease Research Center (ADRC) will build upon research strength at the College of Physicians and Surgeons of Columbia University and combine these with the research experience and clinical care activities at the Burke Rehabilitation Center of Cornell University. By this means, we hope to use the ADRC to bridge the academic activity in these two major clinical and research universities in New York City. In turn, the Center at these two universities will integrate activities at other institutions, such as investigations of cortical connectivity and protein phosphorylation at Rockefeller University, and serve as a focus for investigators throughout the greater New York area. This Alzheimer's Disease Research Center emphasizes research in cell and molecular biology, including the molecular basis of memory, combined with strong research on the clinical aspects of Alzheimer's Disease and the care of Alzheimer's patients. It will include four new research programs in the cellular and molecular mechanisms underlying normal and disordered neuronal growth and neuronal plasticity. These studies will be carried out in parallel with clinical research on the natural history of Alzheimer's Disease and the care of Alzheimer Disease patients. The diversity of different ethnic, racial and economic backgrounds of patients in our populations will provide a unique chance to study how these factors influence care and outcome.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG008702-04
Application #
3104906
Study Section
Aging Review Committee (AGE)
Project Start
1989-09-29
Project End
1994-05-31
Budget Start
1992-07-15
Budget End
1993-05-31
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Qureshi, Yasir H; Patel, Vivek M; Berman, Diego E et al. (2018) An Alzheimer's Disease-Linked Loss-of-Function CLN5 Variant Impairs Cathepsin D Maturation, Consistent with a Retromer Trafficking Defect. Mol Cell Biol 38:
Reitz, Christiane (2018) Retromer Dysfunction and Neurodegenerative Disease. Curr Genomics 19:279-288
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Tariciotti, Leonardo; Casadei, Matthew; Honig, Lawrence S et al. (2018) Clinical Experience with Cerebrospinal Fluid A?42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia. J Alzheimers Dis 65:1417-1425
Masucci, Michael D; Lister, Amanda; Corcoran, Cheryl M et al. (2018) Motor Dysfunction as a Risk Factor for Conversion to Psychosis Independent of Medication Use in a Psychosis-Risk Cohort. J Nerv Ment Dis 206:356-361
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826

Showing the most recent 10 out of 640 publications